|
Diabetes, Vol 46, Issue 1 3-10, Copyright © 1997 by American Diabetes Association
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
G Boden
General Clinical Research Center, Temple University, Philadelphia, Pennsylvania 19140, USA.
Evidence is reviewed that free fatty acids (FFAs) are one important link
between obesity and insulin resistance and NIDDM. First, plasma FFA levels
are elevated in most obese subjects. Second, physiological elevations in
plasma FFA concentrations inhibit insulin stimulated peripheral glucose
uptake in a dose-dependent manner in normal controls and in patients with
NIDDM. Two possible mechanisms are identified: 1) a fat-related inhibition
of glucose transport or phosphorylation, which appears after 3-4 h of fat
infusion, and 2) a decrease in muscle glycogen synthase activity, which
appears after 4-6 h of fat infusion. Third, FFAs stimulate insulin
secretion in nondiabetic individuals. Some of this insulin is transmitted
in the peripheral circulation and is able to compensate for FFA-mediated
peripheral insulin resistance. FFA-mediated portal hyperinsulinemia
counteracts the stimulation of FFAs on hepatic glucose production (HGP) and
thus prevents hepatic glucose overproduction. We speculate that, in obese
individuals who are genetically predisposed to develop NIDDM, FFAs will
eventually fail to promote insulin secretion. The stimulatory effect of
FFAs on HGP would then become unchecked, resulting in hyperglycemia. Hence,
continuously elevated levels of plasma FFAs may play a key role in the
pathogenesis of NIDDM in predisposed individuals by impairing peripheral
glucose utilization and by promoting hepatic glucose overproduction.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Fukuda, J. E. Jones, D. Olson, J. Hill, C. E. Lee, L. Gautron, M. Choi, J. M. Zigman, B. B. Lowell, and J. K. Elmquist
Monitoring FoxO1 Localization in Chemically Identified Neurons
J. Neurosci.,
December 10, 2008;
28(50):
13640 - 13648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Ruddock, A. Stein, E. Landaker, J. Park, R. C. Cooksey, D. McClain, and M.-E. Patti
Saturated Fatty Acids Inhibit Hepatic Insulin Action by Modulating Insulin Receptor Expression and Post-receptor Signalling
J. Biochem.,
November 1, 2008;
144(5):
599 - 607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Boden, W. Song, K. Kresge, M. Mozzoli, and P. Cheung
Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors
Am J Physiol Endocrinol Metab,
September 1, 2008;
295(3):
E692 - E697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dandona, A. Chaudhuri, and H. Ghanim
Insulin Therapy and Lipid Overload in Type 2 Diabetes
JAMA,
August 20, 2008;
300(7):
788 - 789.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Deivanayagam, B S. Mohammed, B. E Vitola, G. H Naguib, T. H Keshen, E. P Kirk, and S. Klein
Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents
Am. J. Clinical Nutrition,
August 1, 2008;
88(2):
257 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kebede, J. Favaloro, J. E. Gunton, D. R. Laybutt, M. Shaw, N. Wong, B. C. Fam, K. Aston-Mourney, C. Rantzau, A. Zulli, et al.
Fructose-1,6-Bisphosphatase Overexpression in Pancreatic {beta}-Cells Results in Reduced Insulin Secretion: A New Mechanism for Fat-Induced Impairment of {beta}-Cell Function
Diabetes,
July 1, 2008;
57(7):
1887 - 1895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Basu, V. Chandramouli, B. Dicke, B. R. Landau, and R. A. Rizza
Plasma C5 Glucose-to-2H2O Ratio Does Not Provide an Accurate Assessment of Gluconeogenesis During Hyperinsulinemic-Euglycemic Clamps in Either Nondiabetic or Diabetic Humans
Diabetes,
July 1, 2008;
57(7):
1800 - 1804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tian, R. F. Corkey, G. C. Yaney, P. B. Goforth, L. S. Satin, and L. Moitoso de Vargas
Differential modulation of L-type calcium channel subunits by oleate
Am J Physiol Endocrinol Metab,
June 1, 2008;
294(6):
E1178 - E1186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P Macfarlane, S. Forbes, and B. R Walker
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
J. Endocrinol.,
May 1, 2008;
197(2):
189 - 204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Coll, E. Eyre, R. Rodriguez-Calvo, X. Palomer, R. M. Sanchez, M. Merlos, J. C. Laguna, and M. Vazquez-Carrera
Oleate Reverses Palmitate-induced Insulin Resistance and Inflammation in Skeletal Muscle Cells
J. Biol. Chem.,
April 25, 2008;
283(17):
11107 - 11116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bikopoulos, A. da Silva Pimenta, S. C Lee, J. R Lakey, S. D Der, C. B Chan, R. B. Ceddia, M. B Wheeler, and M. Rozakis-Adcock
Ex vivo transcriptional profiling of human pancreatic islets following chronic exposure to monounsaturated fatty acids
J. Endocrinol.,
March 1, 2008;
196(3):
455 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Boden, W. Song, L. Pashko, and K. Kresge
In Vivo Effects of Insulin and Free Fatty Acids on Matrix Metalloproteinases in Rat Aorta
Diabetes,
February 1, 2008;
57(2):
476 - 483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Mott, K. Stone, M. C. Gessel, J. C. Bunt, and C. Bogardus
Palmitate action to inhibit glycogen synthase and stimulate protein phosphatase 2A increases with risk factors for type 2 diabetes
Am J Physiol Endocrinol Metab,
February 1, 2008;
294(2):
E444 - E450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Vistisen, L. I Hellgren, T. Vadset, C. Scheede-Bergdahl, J. W. Helge, F. Dela, and B. Stallknecht
Effect of gender on lipid-induced insulin resistance in obese subjects
Eur. J. Endocrinol.,
January 1, 2008;
158(1):
61 - 68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Sabin, M. De Hora, J. M.P. Holly, L. P. Hunt, A. L. Ford, S. R. Williams, J. S. Baker, C. J. Retallick, E. C. Crowne, and J. P.H. Shield
Fasting Nonesterified Fatty Acid Profiles in Childhood and Their Relationship With Adiposity, Insulin Sensitivity, and Lipid Levels
Pediatrics,
December 1, 2007;
120(6):
e1426 - e1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Oprescu, G. Bikopoulos, A. Naassan, E. M. Allister, C. Tang, E. Park, H. Uchino, G. F. Lewis, I. G. Fantus, M. Rozakis-Adcock, et al.
Free Fatty Acid Induced Reduction in Glucose-Stimulated Insulin Secretion: Evidence for a Role of Oxidative Stress In Vitro and In Vivo
Diabetes,
December 1, 2007;
56(12):
2927 - 2937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. A. Nguyen, S. Favelyukis, A.-K. Nguyen, D. Reichart, P. A. Scott, A. Jenn, R. Liu-Bryan, C. K. Glass, J. G. Neels, and J. M. Olefsky
A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways
J. Biol. Chem.,
November 30, 2007;
282(48):
35279 - 35292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Bergman, M.-A. Cornier, T. J. Horton, and D. H. Bessesen
Effects of fasting on insulin action and glucose kinetics in lean and obese men and women
Am J Physiol Endocrinol Metab,
October 1, 2007;
293(4):
E1103 - E1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Weickert, C. v. Loeffelholz, M. Roden, V. Chandramouli, A. Brehm, P. Nowotny, M. A. Osterhoff, F. Isken, J. Spranger, B. R. Landau, et al.
A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects
Am J Physiol Endocrinol Metab,
October 1, 2007;
293(4):
E1078 - E1084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Newsholme, E. P. Haber, S. M. Hirabara, E. L. O. Rebelato, J. Procopio, D. Morgan, H. C. Oliveira-Emilio, A. R. Carpinelli, and R. Curi
Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity
J. Physiol.,
August 15, 2007;
583(1):
9 - 24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tordjman, S. Leroyer, G. Chauvet, J. Quette, C. Chauvet, C. Tomkiewicz, C. Chapron, R. Barouki, C. Forest, M. Aggerbeck, et al.
Cytosolic Aspartate Aminotransferase, a New Partner in Adipocyte Glyceroneogenesis and an Atypical Target of Thiazolidinedione
J. Biol. Chem.,
August 10, 2007;
282(32):
23591 - 23602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lindegaard, C. Frosig, A. M. W. Petersen, P. Plomgaard, S. Ditlevsen, B. Mittendorfer, G. Van Hall, J. F.P. Wojtaszewski, and B. K. Pedersen
Inhibition of Lipolysis Stimulates Peripheral Glucose Uptake but Has No Effect on Endogenous Glucose Production in HIV Lipodystrophy
Diabetes,
August 1, 2007;
56(8):
2070 - 2077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M.L. Tsukumo, M. A. Carvalho-Filho, J. B.C. Carvalheira, P. O. Prada, S. M. Hirabara, A. A. Schenka, E. P. Araujo, J. Vassallo, R. Curi, L. A. Velloso, et al.
Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin Resistance
Diabetes,
August 1, 2007;
56(8):
1986 - 1998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Cusi, S. Kashyap, A. Gastaldelli, M. Bajaj, and E. Cersosimo
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes
Am J Physiol Endocrinol Metab,
June 1, 2007;
292(6):
E1775 - E1781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Y. Liu, Q. F. Collins, Y. Xiong, F. Moukdar, E. G. Lupo Jr., Z. Liu, and W. Cao
Prolonged Treatment of Primary Hepatocytes with Oleate Induces Insulin Resistance through p38 Mitogen-activated Protein Kinase
J. Biol. Chem.,
May 11, 2007;
282(19):
14205 - 14212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Si, S. Palani, A. Jayaraman, and K. Lee
Effects of forced uncoupling protein 1 expression in 3T3-L1 cells on mitochondrial function and lipid metabolism
J. Lipid Res.,
April 1, 2007;
48(4):
826 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Savage, K. F. Petersen, and G. I. Shulman
Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance
Physiol Rev,
April 1, 2007;
87(2):
507 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fontana, J. C. Eagon, M. E. Trujillo, P. E. Scherer, and S. Klein
Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans
Diabetes,
April 1, 2007;
56(4):
1010 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Dunstan, J. Salmon, G. N. Healy, J. E. Shaw, D. Jolley, P. Z. Zimmet, N. Owen, and on behalf of the AusDiab Steering Committee
Association of Television Viewing With Fasting and 2-h Postchallenge Plasma Glucose Levels in Adults Without Diagnosed Diabetes
Diabetes Care,
March 1, 2007;
30(3):
516 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ukropcova, O. Sereda, L. de Jonge, I. Bogacka, T. Nguyen, H. Xie, G. A. Bray, and S. R. Smith
Family History of Diabetes Links Impaired Substrate Switching and Reduced Mitochondrial Content in Skeletal Muscle
Diabetes,
March 1, 2007;
56(3):
720 - 727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Xu, K. Chakravarty, X. Kong, T. T. Tuy, I. J. Arinze, F. Bone, and D. Massillon
Several Transcription Factors Are Recruited to the Glucose-6-Phosphatase Gene Promoter in Response to Palmitate in Rat Hepatocytes and H4IIE Cells
J. Nutr.,
March 1, 2007;
137(3):
554 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Saadeh
Nonalcoholic Fatty Liver Disease and Obesity
Nutr Clin Pract,
February 1, 2007;
22(1):
1 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Friedlander, J. Weinreb, I. Friedlander, and J. A. Yagiela
Metabolic syndrome: Pathogenesis, medical care and dental implications
J Am Dent Assoc,
February 1, 2007;
138(2):
179 - 187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. T. Goh, T. M. Mason, N. Gupta, A. So, T. K. T. Lam, L. Lam, G. F. Lewis, A. Mari, and A. Giacca
Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure
Am J Physiol Endocrinol Metab,
February 1, 2007;
292(2):
E549 - E560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Boden, C. Homko, M. Mozzoli, M. Zhang, K. Kresge, and P. Cheung
Combined Use of Rosiglitazone and Fenofibrate in Patients With Type 2 Diabetes: Prevention of Fluid Retention
Diabetes,
January 1, 2007;
56(1):
248 - 255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Gao, Z. Wang, X. Zhang, A. A. Butler, A. Zuberi, B. Gawronska-Kozak, M. Lefevre, D. York, E. Ravussin, H.-R. Berthoud, et al.
Inactivation of PKC{theta} leads to increased susceptibility to obesity and dietary insulin resistance in mice
Am J Physiol Endocrinol Metab,
January 1, 2007;
292(1):
E84 - E91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ha, M.-J. Kim, B.-K. Choi, J.-J. Rho, D.-J. Oh, T.-H. Rho, K.-H. Kim, H. J. Lee, D.-H. Shin, S. V. Yim, et al.
Positive Association of Obesity with Single Nucleotide Polymorphisms of Syndecan 3 in the Korean Population
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
5095 - 5099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Coll, M. Jove, R. Rodriguez-Calvo, E. Eyre, X. Palomer, R. M. Sanchez, M. Merlos, J. C. Laguna, and M. Vazquez-Carrera
Palmitate-Mediated Downregulation of Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator 1{alpha} in Skeletal Muscle Cells Involves MEK1/2 and Nuclear Factor-{kappa}B Activation.
Diabetes,
October 1, 2006;
55(10):
2779 - 2787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Willsky, L.-H. Chi, Y. Liang, D. P. Gaile, Z. Hu, and D. C. Crans
Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate
Physiol Genomics,
September 14, 2006;
26(3):
192 - 201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kamei, K. Tobe, R. Suzuki, M. Ohsugi, T. Watanabe, N. Kubota, N. Ohtsuka-Kowatari, K. Kumagai, K. Sakamoto, M. Kobayashi, et al.
Overexpression of Monocyte Chemoattractant Protein-1 in Adipose Tissues Causes Macrophage Recruitment and Insulin Resistance
J. Biol. Chem.,
September 8, 2006;
281(36):
26602 - 26614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. F. Collins, Y. Xiong, E. G. Lupo Jr., H.-Y. Liu, and W. Cao
p38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes
J. Biol. Chem.,
August 25, 2006;
281(34):
24336 - 24344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Doege and A. Stahl
Protein-mediated Fatty Acid uptake: novel insights from in vivo models.
Physiology,
August 1, 2006;
21:
259 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pagano, C. Pilon, M. Olivieri, P. Mason, R. Fabris, R. Serra, G. Milan, M. Rossato, G. Federspil, and R. Vettor
Reduced Plasma Visfatin/Pre-B Cell Colony-Enhancing Factor in Obesity Is Not Related to Insulin Resistance in Humans
J. Clin. Endocrinol. Metab.,
August 1, 2006;
91(8):
3165 - 3170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tuncman, J. Hirosumi, G. Solinas, L. Chang, M. Karin, and G. S. Hotamisligil
Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance
PNAS,
July 11, 2006;
103(28):
10741 - 10746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kishore, J. Tonelli, S. Koppaka, C. Fratila, A. Bose, D.-E. Lee, K. Reddy, and M. Hawkins
Time-Dependent Effects of Free Fatty Acids on Glucose Effectiveness in Type 2 Diabetes
Diabetes,
June 1, 2006;
55(6):
1761 - 1768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. van Weel, M. de Vries, P. J. Voshol, R. E. Verloop, P. H.C. Eilers, V. W.M. van Hinsbergh, J. H. van Bockel, and P. H.A. Quax
Hypercholesterolemia Reduces Collateral Artery Growth More Dominantly Than Hyperglycemia or Insulin Resistance in Mice
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2006;
26(6):
1383 - 1390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, M. Bosch-Marce, A. Nanayakkara, V. Savransky, S. K. Fried, G. L. Semenza, and V. Y. Polotsky
Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1{alpha}
Physiol Genomics,
May 16, 2006;
25(3):
450 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Leroyer, J. Tordjman, G. Chauvet, J. Quette, C. Chapron, C. Forest, and B. Antoine
Rosiglitazone Controls Fatty Acid Cycling in Human Adipose Tissue by Means of Glyceroneogenesis and Glycerol Phosphorylation
J. Biol. Chem.,
May 12, 2006;
281(19):
13141 - 13149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Wu, A. M. Ortegon, B. Tsang, H. Doege, K. R. Feingold, and A. Stahl
FATP1 Is an Insulin-Sensitive Fatty Acid Transporter Involved in Diet-Induced Obesity.
Mol. Cell. Biol.,
May 1, 2006;
26(9):
3455 - 3467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. M. W. van Kempen, S. N. van der Crabben, M. T. Ackermans, E. Endert, J. H. Kok, and H. P. Sauerwein
Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile
Am J Physiol Endocrinol Metab,
April 1, 2006;
290(4):
E723 - E730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. De Caterina, A. Zampolli, S. Del Turco, R. Madonna, and M. Massaro
Nutritional mechanisms that influence cardiovascular disease
Am. J. Clinical Nutrition,
February 1, 2006;
83(2):
421S - 426S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jove, A. Planavila, R. M. Sanchez, M. Merlos, J. C. Laguna, and M. Vazquez-Carrera
Palmitate Induces Tumor Necrosis Factor-{alpha} Expression in C2C12 Skeletal Muscle Cells by a Mechanism Involving Protein Kinase C and Nuclear Factor-{kappa}B Activation
Endocrinology,
January 1, 2006;
147(1):
552 - 561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Woerle, E. Szoke, C. Meyer, J. M. Dostou, S. D. Wittlin, N. R. Gosmanov, S. L. Welle, and J. E. Gerich
Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
Am J Physiol Endocrinol Metab,
January 1, 2006;
290(1):
E67 - E77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Claus, D. B. Lowe, Y. Liang, A. I. Salhanick, C. K. Lubeski, L. Yang, L. Lemoine, J. Zhu, and K. B. Clairmont
Specific Inhibition of Hormone-Sensitive Lipase Improves Lipid Profile while Reducing Plasma Glucose
J. Pharmacol. Exp. Ther.,
December 1, 2005;
315(3):
1396 - 1402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Park, Y.-R. Cho, H.-J. Kim, T. Higashimori, C. Danton, M.-K. Lee, A. Dey, B. Rothermel, Y.-B. Kim, A. Kalinowski, et al.
Unraveling the Temporal Pattern of Diet-Induced Insulin Resistance in Individual Organs and Cardiac Dysfunction in C57BL/6 Mice
Diabetes,
December 1, 2005;
54(12):
3530 - 3540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Watson, S. Hahm, T. M. Mizuno, J. Windsor, C. Montgomery, P. E. Scherer, C. V. Mobbs, and S. R. J. Salton
VGF Ablation Blocks the Development of Hyperinsulinemia and Hyperglycemia in Several Mouse Models of Obesity
Endocrinology,
December 1, 2005;
146(12):
5151 - 5163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bajaj, S. Suraamornkul, A. Romanelli, G. W. Cline, L. J. Mandarino, G. I. Shulman, and R. A. DeFronzo
Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long-Chain Fatty Acyl-CoAs and Insulin Action in Type 2 Diabetic Patients
Diabetes,
November 1, 2005;
54(11):
3148 - 3153.
[Abstract]
[Full Text]
[PDF]
|
 |
| |